Answer By law4u team
The Cartagena Protocol on Biosafety is an international agreement adopted in 2000 under the Convention on Biological Diversity (CBD). It aims to ensure the safe handling, transport, and use of living modified organisms (LMOs), also known as genetically modified organisms (GMOs), which may have adverse effects on biodiversity and human health. The Protocol establishes procedures for risk assessment, information exchange, and decision-making to protect biological diversity. India, a party to the Protocol since 2003, has actively engaged in its implementation to strengthen national biosafety regulations and promote responsible biotechnology use.
What is the Cartagena Protocol on Biosafety?
Purpose and Scope
The Protocol provides a framework for regulating the transboundary movement of LMOs to prevent potential risks to biodiversity and human health. It promotes informed decision-making and public awareness regarding GMOs.
Key Provisions
Advance Informed Agreement (AIA): Requires exporting countries to notify importing countries before the first intentional transboundary movement of LMOs.
Risk Assessment: Parties must conduct scientific assessments of LMOs to evaluate potential adverse effects.
Information Sharing: Establishes a Biosafety Clearing-House (BCH) for sharing information on LMOs.
Public Participation: Encourages involvement of the public and stakeholders in biosafety decision-making.
India’s Participation
Ratification and Legal Framework
India ratified the Cartagena Protocol in 2003 and incorporated its principles into the national regulatory framework through the Environment Protection Act and Rules on Biosafety.
Biosafety Regulations
India established the Genetic Engineering Appraisal Committee (GEAC) under the Ministry of Environment, Forest and Climate Change (MoEFCC) to oversee GMO approvals and compliance with biosafety guidelines.
Risk Assessment and Management
India conducts rigorous scientific risk assessments of GMOs before approving their use in agriculture, industry, or research.
Information Exchange and Capacity Building
India actively participates in the Protocol’s Biosafety Clearing-House, sharing data and best practices. It also conducts training programs to enhance biosafety capacity among regulators and scientists.
Public Awareness and Stakeholder Engagement
The government promotes awareness campaigns and consults with various stakeholders, including farmers, industry, and environmental groups, to ensure transparent biosafety governance.
Example
Scenario: India reviews the approval process for a new genetically modified crop.
Steps Taken:
The GEAC conducts a thorough risk assessment of the GMO’s environmental and health impacts.
India informs other countries through the Biosafety Clearing-House about the GMO’s transboundary movement.
Stakeholders, including farmers and experts, are consulted in public hearings.
Conditions for safe handling and monitoring are established before approval.
Post-release monitoring ensures compliance and addresses any biosafety concerns.
This example illustrates India’s commitment to the Cartagena Protocol’s objectives and responsible biotechnology management.
